Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

MEREO BIOPHARMA GROUP PLC

(MREO)
  Report
Delayed Nasdaq  -  04:00 2022-09-26 pm EDT
0.8236 USD   -2.15%
09/26Mereo BioPharma Says Rubric Capital Management Rejected Offer to Resolve Proxy Contest
MT
09/26Mereo BioPharma Offered to Settle Proxy Contest with Rubric Capital Management by Putting Rubric Principal and Second New Director on the Board
AQ
09/23Rubric Capital Management Issues Open Letter to Mereo BioPharma Shareholders
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about MEREO BIOPHARMA GROUP PLC
09/26Mereo BioPharma Says Rubric Capital Management Rejected Offer to Resolve Proxy Contest
MT
09/26Mereo BioPharma Offered to Settle Proxy Contest with Rubric Capital Management by Putti..
AQ
09/23Rubric Capital Management Issues Open Letter to Mereo BioPharma Shareholders
CI
09/14Rubric Capital Management Issues Open Letter to Mereo BioPharma Shareholders
BU
09/14Rubric Capital Management LP Issues a Letter to the Shareholders of Mereo BioPharma Gro..
CI
09/12Mereo BioPharma Reports Clinical Update and Interim Biomarker Analysis Presented at ESM..
AQ
09/12Mereo Biopharma Group plc Reports Clinical Update and Interim Biomarker Analysis Presen..
CI
08/31Mereo BioPharma Sends Letter to Rubric Capital Management
AQ
08/31Mereo BioPharma Group plc Sends a Letter to Rubric Capital Management
CI
08/24Rubric Capital Management LP Delivers a Letter to Mereo BioPharma Group
CI
08/22Mereo BioPharma Group Responds to Investor Rubric's Proposal to Replace Four Directors,..
MT
08/22Mereo BioPharma Sends Letter to Rubric Capital Management
AQ
08/22Mereo BioPharma Group Sends a Letter to Rubric Capital Management LP
CI
08/12Cantor Fitzgerald Starts Mereo BioPharma Group at Overweight With $4 Price Target
MT
07/05Mereo Biopharma : Regains Compliance with Nasdaq Minimum Bid Price Requirement - Form 6-K
PU
More most relevant news
All news about MEREO BIOPHARMA GROUP PLC
09/26Mereo BioPharma Says Rubric Capital Management Rejected Offer to Resolve Proxy Contest
MT
09/26Mereo BioPharma Offered to Settle Proxy Contest with Rubric Capital Management by Putti..
AQ
09/23Rubric Capital Management Issues Open Letter to Mereo BioPharma Shareholders
CI
09/22European ADRs Move Lower in Thursday Trading
MT
09/21European ADRs Move Lower in Wednesday Trading
MT
09/14European ADRs Move Slightly Higher in Wednesday Trading
MT
09/14Rubric Capital Management Issues Open Letter to Mereo BioPharma Shareholders
BU
09/14Rubric Capital Management LP Issues a Letter to the Shareholders of Mereo BioPharma Gro..
CI
09/13European ADRs Drop Sharply in Tuesday Trading
MT
09/12Ultragenyx and Mereo BioPharma to Present Setrusumab Data Update at ASBMR
AQ
More news
News in other languages on MEREO BIOPHARMA GROUP PLC
09/26Mereo BioPharma affirme que Rubric Capital Management a rejeté l'offre de résolution de..
09/23Rubric Capital Management publie une lettre ouverte aux actionnaires de Mereo BioPharma
09/22Les ADR européens sont en baisse jeudi
09/21Les ADR européens sont en baisse mercredi
09/14Les ADR européens progressent légèrement dans la négociation de mercredi
09/14Rubric Capital Management LP publie une lettre aux actionnaires de Mereo BioPharma Grou..
09/13Les ADR européens chutent fortement dans la négociation de mardi
09/12Mereo Biopharma Group plc fait état d'une mise à jour clinique et d'une analyse intérim..
09/09Les ADR européens en forte hausse dans les échanges de vendredi
09/08Les ADR européens progressent légèrement dans les échanges de jeudi
More news
Analyst Recommendations on MEREO BIOPHARMA GROUP PLC
08/12Cantor Fitzgerald Starts Mereo BioPharma Group at Overweight With $4 Price Target
MT
06/06Needham Adjusts Price Target on Mereo BioPharma Group to $5 From $10, Reiterates Buy Ra..
MT
2021Mereo BioPharma : BTIG Initiates Mereo BioPharma at Buy Rating With $10 ..
MT
2021Mereo BioPharma : Needham Starts Mereo BioPharma Group at Buy With $10 P..
MT
More recommendations
Press releases
09/26Mereo BioPharma Offered to Settle Proxy Contest with Rubric Capital Management by Putti..
AQ
09/14Rubric Capital Management Issues Open Letter to Mereo BioPharma Shareholders
BU
09/12Ultragenyx and Mereo BioPharma to Present Setrusumab Data Update at ASBMR
AQ
09/12Mereo BioPharma Reports Clinical Update and Interim Biomarker Analysis Presented at ESM..
AQ
08/31Mereo BioPharma Sends Letter to Rubric Capital Management
AQ
More press releases
Upcoming event on MEREO BIOPHARMA GROUP PLC